Science

Latest articles

Biotherapeutics: What Do We Make Next?

For years, computational methods for small molecule drug design have offered numerous algorithms and methodologies to help generate new ideas and guide the iterative process of lead design and…

Precision Polymer Modeling: Leveraging Materials Studio and Scripting Innovations

Materials Studio offers a user-friendly yet powerful platform for modeling a huge range of systems, with this report focusing specifically on polymers and polymer networks…

Miko Stulajter’s BIOVIA Internship: Prototyping and New Features in BIOVIA Molecular Design

Miko Stulajter completed a second three-month summer 3DEXPERIENCE® scientific visualization internship with the BIOVIA R&D software engineering team. After a rewarding first internship experience…

What is NLP? (Natural Language Processing)

Explore the benefits and challenges of NLP and how it is revolutionizing industry.

Intern Spotlight: An Investigation into New DFTB + Parameterisation Techniques

Watch this video to learn about Fred Kirk’s summer internship on the BIOVIA Quantum Mechanics team at Dassault Systemes.

Forcefield Optimization for Energetic Materials

Discover how BIOVIA’s computational tools advance the study of molecular crystals, including crystal structure prediction, lattice energy calculations, and the latest COMPASSIII forcefield developments.

Virtual Twin Experience Powered by Data Science for the Aerospace & Defense Industry

Read (or watch) the conversation between Morgan Zimmermann, CEO of NETVIBES, and David Ziegler, Vice President Aerospace & Defense Industry at Dassault Systèmes, about industry challenges and solutions proposed by virtual twin experiences on the 3DEXPERIENCE platform.

Development of Innovative Drugs Using Materials Studio

Discover how BIOVIA Materials Studio, with the Martini 3 force field, enhances lipid nanoparticle and membrane simulations for advanced drug delivery systems. Explore the benefits of molecular dynamics and coarse-grained simulations in optimizing therapeutic formulations.